Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
NCT02768389Phase 1Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Sep 2016
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in glioblastoma (GBM), sponsored by Case Comprehensive Cancer Center. Primary endpoints: Number of subjects following Modified Atkins Diet at 12 weeks and Number of subjects with ketosis at 12 weeks. Started Sep 2016; status: completed.
02
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02768389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768389.